• Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
    2025/10/17

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects.

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    26 分
  • The Role of Neuroimaging in Diagnosis of Alzheimer Disease
    2025/10/17

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of Neuroimaging in Diagnosis of Alzheimer Disease along with Jason Karlawish, MD, Professor of Medicine, medical ethics and health policy, and neurology at the University of Pennsylvania Perelman School of Medicine and Co-Associate Director of the Alzheimer’s Disease Research Center, and Co-Director of the Penn Memory Center.

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    17 分
  • How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
    2025/10/16

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Lolita Nidadavolu, Assistant Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, as they discuss How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters).

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    33 分
  • Evidence Review of FDA-Approved Monoclonal Antibody Treatments
    2025/10/15

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San Francisco VA Medical Center who, co-authored the module titled Evidence Review of FDA-Approved Monoclonal Antibody Treatments along with Kaitlin Willham, MD, Outpatient Geriatrics Clinic Medical Director at the San Francisco VA and Associate Professor of Medicine, at UCSF Division of Geriatrics.

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    24 分
  • Pathology and Diagnostic Frameworks for Alzheimer Disease
    2025/10/15

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Heather E. Whitson, Distinguished Professor of Neuroscience, Professor of Medicine (Geriatrics), Director of the Duke Aging Center and the Co-director of the Duke/UNC Alzheimer’s Disease Research Center, as they discuss Pathology and Diagnostic Frameworks for Alzheimer Disease.

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    24 分
  • Evaluation of Cognition and Cognitive Disorder
    2025/10/15

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Esther Oh, Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine and Co-Director, Johns Hopkins Memory and Alzheimer's Treatment Center and; Dr. Mfon E. Umoh, Assistant Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, as they discuss Evaluation of Cognition and Cognitive Disorder.

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    28 分
  • Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive
    2025/10/15

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Sharon Brangman, Professor of Geriatric Medicine, Chief of the Department of Geriatrics, Director of the Center of Excellence for Alzheimer's Disease (CEAD), Director of University Geriatricians, and Chair of the Department of Geriatrics at SUNY Upstate University Hospital; and Dr. Alejandra Sanchez Lopez, Assistant Clinical Professor of Neurology and Geriatric Medicine at UCLA, as they discuss Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence is Not Inclusive.

    To view a transcript click here then select the transcript tab.

    続きを読む 一部表示
    20 分